Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Actelion Looks To Open Up Secondary Markets For Tracleer

Aug. 21, 2002

By Cormac Sheridan

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

Elan Selling Off Assets, Cutting Employees In Restructuring Plan

Aug. 7, 2002

By Cormac Sheridan

Elan Selling Off Assets, Cutting Employees In Restructuring Plan

Aug. 7, 2002

By Cormac Sheridan

Genmab Pulling Listing From Germany's Troubled Neuer Markt

July 31, 2002

By Cormac Sheridan

Genmab Pulling Listing From Germany's Troubled Neuer Markt

July 31, 2002

By Cormac Sheridan

Stem Cell Research Center To Push Science In Denmark

July 24, 2002

By Cormac Sheridan

Stem Cell Research Center To Push Science In Denmark

July 24, 2002

By Cormac Sheridan

Swiss Start-Up Addex Raises CHF15.75M To Treat Addiction

July 17, 2002

By Cormac Sheridan

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...